YUKIO TAKESHIMA

Last Updated :2024/02/02

Affiliations, Positions
Graduate School of Biomedical and Health Sciences(Medicine), Professor
Web Site
E-mail
ykotakehiroshima-u.ac.jp
Self-introduction
We purse a technique for more precise & rapid pathogical diagnosis by fusion of pathological morphology and molecular biology. Among various diseases, we are making efforts of novel markes detection for accurate pathological malignant mesotheliomas related asbestos-exposure.

Basic Information

Major Professional Backgrounds

  • 2000/04/07, 2012/06/30, Hiroshima University, Assistant Professor
  • 1991/04/01, 1995/03/31, Hiroshima University, Research Associate
  • 1995/04/01, 1995/04/30, Hiroshima University, Research Associate
  • 1995/05/01, 2000/03/31, Hiroshima University, Lecturer
  • 2012/07/01, 2019/03/31, Dept of Pathology, Institutes of Biomedical & Health Sciences, Professor
  • 2019/04/01, Hiroshima University, Graduate School of Biomedical & Health Sciences, Professor

Academic Degrees

  • Doctor of Philosophy in Medical Science, Hiroshima University

Educational Activity

  • [Bachelor Degree Program] School of Medicine : Program of Medicine : Medicine
  • [Master's Program] Graduate School of Biomedical and Health Sciences : Division of Integrated Health Sciences : Program of Biomedical Science
  • [Doctoral Program] Graduate School of Biomedical and Health Sciences : Division of Integrated Health Sciences : Program of Biomedical Science
  • [Doctoral Program] Graduate School of Biomedical and Health Sciences : Division of Biomedical Sciences : Program of Medicine

In Charge of Primary Major Programs

  • Medicine

Research Fields

  • Medicine,dentistry, and pharmacy;Basic medicine;Human pathology

Research Keywords

  • Pathology
  • Environmental Carcinogenesis
  • Occupational cancer
  • mesothelioma
  • Lung cancer
  • molecular biology
  • Pathological Diagnosis
  • Autopsy
  • Digital pathology

Affiliated Academic Societies

Educational Activity

Course in Charge

  1. 2023, Graduate Education (Master's Program) , Second Semester, Research
  2. 2023, Graduate Education (Doctoral Program) , First Semester, Advanced Seminar
  3. 2023, Graduate Education (Doctoral Program) , Second Semester, Advanced Seminar
  4. 2023, Graduate Education (Doctoral Program) , First Semester, Advanced Research
  5. 2023, Graduate Education (Doctoral Program) , Second Semester, Advanced Research
  6. 2023, Graduate Education (Master's Program) , Second Semester, Pathologic Basis of Diseases
  7. 2023, Graduate Education (Doctoral Program) , First Semester, Advanced Seminar on Pathology
  8. 2023, Graduate Education (Doctoral Program) , Second Semester, Advanced Seminar on Pathology
  9. 2023, Graduate Education (Doctoral Program) , First Semester, Advanced Research on Pathology
  10. 2023, Graduate Education (Doctoral Program) , Second Semester, Advanced Research on Pathology
  11. 2023, Liberal Arts Education Program1, 2Term, Peace Messages from "Kasumi Campus"
  12. 2023, Undergraduate Education, Second Semester, Clinical Pathology
  13. 2023, Undergraduate Education, 2Term, Introduction for medical research
  14. 2023, Undergraduate Education, Intensive, Practice for medical research
  15. 2023, Undergraduate Education, Intensive, Practice of Medicine I
  16. 2023, Undergraduate Education, Intensive, Practice of Medicine II
  17. 2023, Undergraduate Education, First Semester, General Pathology
  18. 2023, Undergraduate Education, First Semester, Pathology
  19. 2023, Undergraduate Education, First Semester, Pathology
  20. 2023, Undergraduate Education, Intensive, Pathology
  21. 2023, Undergraduate Education, First Semester, Outline of Pathology
  22. 2023, Graduate Education (Master's Program) , First Semester, Seminar
  23. 2023, Graduate Education (Master's Program) , Second Semester, Seminar
  24. 2023, Graduate Education (Master's Program) , First Semester, Research

Research Activities

Academic Papers

  1. Usefulness of NF2 hemizygous loss detected by fluorescence in situ hybridization in diagnosing pleural mesothelioma in tissue and cytology material: A multi-institutional study, Lung Cancer, 175(1), 27-35, 2022
  2. Distribution and prognostic impact of EGFR and KRAS mutations according to histological subtype and tumor invasion status in pTis-3N0M0 lung adenocarcinoma, BMC CANCER, 23(1), 20230314
  3. Insulin-Like Growth Factor 2 mRNA Binding Protein 3 Promotes Cell Proliferation of Malignant Mesothelioma Cells by Downregulating p27(Kip1), FRONTIERS IN ONCOLOGY, 11, 20220119
  4. Serum S100 calcium-binding protein A4 as a novel predictive marker of acute exacerbation of interstitial pneumonia after surgery for lung cancer, BMC PULMONARY MEDICINE, 21(1), 20210602
  5. MUC4 immunohistochemistry is useful in distinguishing epithelioid mesothelioma from adenocarcinoma and squamous cell carcinoma of the lung, SCIENTIFIC REPORTS, 8, 20180109
  6. Therapeutic strategies and genetic profile comparisons in small cell carcinoma and large cell neuroendocrine carcinoma of the lung using next-generation sequencing, ONCOTARGET, 8(65), 108936-108945, 20171212
  7. Histone H2A T120 Phosphorylation Promotes Oncogenic Transformation via Upregulation of Cyclin D1, MOLECULAR CELL, 64(1), 176-188, 20161006
  8. Multicentric Glioma Develops via a Mutant IDH1-Independent Pathway: Immunohistochemical Study of Multicentric Glioma., Pathobiology., 2016 Aug 24. [Epub ahead of print](2016 Aug 24. [Epub ahead of print]), 2016 Aug 24. [Epub ahead of print]-2016 Aug 24. [Epub ahead of print], 20160824
  9. CD26 Overexpression Is Associated with Prolonged Survival and Enhanced Chemosensitivity in Malignant Pleural Mesothelioma, CLINICAL CANCER RESEARCH, 18(5), 1447-1456, 20120301
  10. Myogenic antigen expression is useful for differentiation between epithelioid mesothelioma and non-neoplastic mesothelial cells., Histopathology, 56(7), 969-74, 20100601
  11. Evaluation of apoptosis and immunohistochemical expression of the apoptosis-related proteins in mesothelioma., Hiroshima Journal of Medical Sciences, 59(2), 27-33, 20100601
  12. A case of nodular female breast fasciitis, J. Jpn. Soc. Clin. Cytol., 48(4), 201-205, 20090722
  13. Letter to the Editor, PATHOLOGY INTERNATIONAL, 59(4), 274-274, 20090401
  14. Clinicopathological and immunohistochemical features of three pilomyxoid astrocytomas : Comparative study with 11 pilocytic astrocytomas, 59(2), 80-85, 20090201
  15. Reg IV is an independent prognostic factor for relapse in patients with clinically localized prostate cancer, Cancer Sci, 99(8), 1570-1577, 20080810
  16. Differential diagnosis of sarcomatoid mesothelioma from true sarcoma and sarcomatoid carcinoma using immunohistochemistry, Pathol Int, 58(2), 75-83, 20080201
  17. Characterization of SEZ6L2 cell-surface protein as a novel prognostic marker for lung cancer, Cancer Sci, 97(8), 737-745, 20060810
  18. Expression of vascular endothelial growth factor-C and its receptor in invasive micropapillary carcinoma of the breast, 56(5), 256-261, 20060501
  19. The Reversed Apical Pattern of MUC1 Expression Is Characteristics of Invasive Micropapillary Carcinoma of the Breast, Breast Cancer, 13(1), 58-63, 20060105
  20. A Case of Desmoplastic Malignant Pleural Mesothelioma Treated With Induction Chemotherapy and Subsequent Extrapleural Pneumonectomy, Japanese Journal of Lung Cancer, 45(7), 851-856, 20051220
  21. Increases of amphiregulin and transforming growth factor-alpha in serum as predictors of poor response to gefitinib among patients with advanced non-small cell lung cancers, CANCER RESEARCH, 65(20), 9176-9184, 20051015
  22. Loss of expression of E-cadherin and β-catenin is associated with progression of pulmonary adenocarcinoma, 55(1), 14-18, 20050101
  23. Esophageal carcinosarcoma with basaloid squamous carcinoma and rhabdomyosarcoma components with TP53 mutation, Pathol Int, 54(10), 803-809, 20041001
  24. Inactivation of the p16 gene by hypermethylation and loss of heterozygosity in adenocarcinoma of the lung, Pathol Int, 54(7), 486-489, 20040701
  25. Meningioma in mature cystic teratoma of the ovary, Pathol Int, 54(7), 543-548, 20040701
  26. Nucleosomal histone kinase-1 phosphorylates H2A Thr 119 during mitosis in the early Drosophila embryo, GENES & DEVELOPMENT, 18(8), 877-888, 20040415
  27. Granulocyte-Macrophage Colony-Stimulating Factor and Granulocyte Colony-Stimulating Factor-Producing Malignant Pleural Mesothelioma Accompanied by Eosinophilic Pleural Fluid, Japanese Journal of Lung Cancer, 44(1), 25-30, 20040220
  28. Myxopapillary ependymoma with anaplastic features, 53(10), 700-703, 20031001
  29. Case of clear cell ependymoma of medulla oblongata : Clinicopathological and immunohistochemical study with literature review, Pathol Int, 53(5), 297-302, 20030501
  30. Co-existence of Carcinosarcoma and Adenoid Basal Carcinoma of the Uterine Cervix with Special Reference toits Correlation with Human Papilloma Virus Infection., Int. J Gynecol Pathol., 21(2), 186-190, 20020401
  31. Loss of heterozygosity and microsatellite instability in epithelial hyperplasia of the breast, Journal of Experimental Therapeutics and Oncology, 2(1), 9-18, 20020401
  32. Co-existent carcinosarcoma and adenoid basal carcinoma of the uterine cervix and correlation with human papilloma virus infection, International Journal of Gynecological Pathology, 21(2), 186-190, 20020401
  33. Co-existent carcinosarcoma and adenoid basal carcinoma of the uterine cervix and correlation with human papillomavirus infection., Int. J Gynecol Pathol., 21(2), 186-90, 20020401
  34. Heterogeneity of expression of cytokeratin subtypes in squamous cell carcinoma of the lung : With special reference to CK14 overexpression in cancer of high-proliferative and lymphogenous metastatic potential, 52(4), 286-293, 20020401
  35. Meningioangiomatosis Occurring in a Young Male without Neurofibromatosis -With Special Reference to its Histogenesis and LOH in the NF2 Gene Region-, Am. J. Surg. Pathol., 26(1), 125-126, 20020101
  36. Meningioangiomatosis occurring in a young male without neurofibromatosis: with special reference to its histogenesis and loss of heterozygosity in the NF2 gene region., Am. J. Surg. Pathol., 26(1), 125-129, 20020101
  37. Heterogeneous Genetic Alterations in Ovarian Mucinous Tumors-Application and Usefulness of Laser Capture Microdissection-, Human Pathology, 32(11), 1203-1208, 20011101
  38. An Extraabdominal Desmoid Tumor Presenting as an Intrathoracic Tumor (Intrathoracic Desmoid Tumor): A Case Report and Review of Literature., Pathol. Int., 824-828, 20011001
  39. Extra-abdominal desmoid tumor presenting as an intrathoracic tumor : Case report and literature review, Pathol Int, 51(10), 824-828, 20011001
  40. Loss of heterozygosity and microsatellite instability in epithelial hyperplasia of the breast, J. Exp. Ther. Oncol., 2(1), 1-10, 20010901
  41. PARAGANGLIOMA OF THE URINARY BLADDER : A CASE REPORT, 63(3), 151-153, 20010320
  42. In Vivo Histological Changes Occurring in Hydroxyapatite Cranial Reconstruction, 神経外科, 41(2), 100-104, 20010215
  43. Correlation between morphological heterogeneity and genetic alteration within one tumor in adenocarcinomas of the lung, Pathology International, 50(11), 891-896, 20001101
  44. Correlation between genetic alterations and histopathological subtypes in bronchiolo-alveolar carcinoma and atypical adenomatous hyperplasia of the lung, Pathology International, 50(10), 778-785, 20001001
  45. Genetic Alterations in Ovarian Mucinous Tumors -with Special Reference to the Histogenesis-, Acta Histochem Cytochem, 123-129, 20000201
  46. Idiopathic granulomatous meningoencephalitis presenting as an intracranial tumor., Pathol. Int., 49(12), 1084-1088, 19991201
  47. Idiopathic granulomatous meningoencephalitis presenting as an intracranial tumor, Pathology International, 49(12), 1084-1088, 19991201
  48. Correlation Among Histological Subtypes, Clinicopathological Factors, Expression of p53 Protein and Proliferative Activity in Adenocarcinoma of the Lung, Japanese Journal of Lung Cancer, 39(7), 995-1000, 19991201
  49. Down-regulation of KAI1 Messenger RNA Expression Is Not Associated with Loss of Heterozygosity of the KAI1 Gene Region in Lung Adenocarcinoma, Jpn J Cancer Res, 90(9), 970-976, 19990930
  50. p21WAF1/CIP1 Expression in Primary Lung Adenocarcinomas: Heterogeneous Expression in Tumor Tissues and Correlation with p53 Expression and Proliferative Activities., Carcinogenesis, 19(10), 1755-1761, 19981001
  51. Angiomyofibroblastoma of the vulva : A mitotically active variant?, Pathology International, 48, 292-296, 19980401
  52. Tubular Seminoma of the testis : Report of a Case, Patholgy International, 49, 676-679, 19980401
  53. Solitary fibrous tumor of the prostate, Pathology International, 47, 713-717, 19970401
  54. p16/CDKN2 gene and p53 gene alterations in Japanese non-smoking female lung adenocarcinoma, Jpn.J.Cancer Res., 87, 134-140, 19960401
  55. p16/CDKN2 Gene and p53 Geno Alteration in Japanese Non-smoking Female Lung Adenocarcinoma, Jpn J Cancer Res, 87(2), 134-140, 19960229
  56. p16/CDKN2 Gene and p53 Gene Alterations in Japanese Non-smoking Female Lung Adenocarcioma., Jpn.J.Cancer Res., 134-140, 19960201
  57. Primary Carcinoid Tumor of the Kidney with Special Reference to its Histogenesis., Pathol. Int., 894-900, 19960101
  58. Effects of K-ras Gene Mutations in the Development of Lung Lesions Induced by 4-(N-Methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone in A/J Mice, Jpn J Cancer Res, 87(1), 44-50, 19960101
  59. PATHOLOGY OF RESPIRATORY TRACT IN FORMER WORKERS IN MUSTARD GAS FACTORY : A REVIEW, J Toxicol Pathol, 8(4), 343-353, 19951201
  60. An Autopsy Case of Malignant Pleural Mesothelioma with Prominent Deposition of Chrysotile in the Lung, Japanese Journal of Lung Cancer, 35(6), 783-788, 19951020
  61. Pathological Findings of Atypical Carcinoid Tumors of the Thymus, Japanese Journal of Lung Cancer, 34(7), 1093-1098, 19941220
  62. p53 Protein Accumulates Frequently in Early Bronchial Neoplasia., Cancer Res., 1-6, 19930701
  63. A Clinicopathological Study of Carcinoembryonic Antigen (CEA) Expression Patterns in Small-sized Adenocarcinomas of the Lung, Japanese Journal of Lung Cancer, 32(7), 1049-1057, 19921220
  64. A Clinicopathological Study of Adenosquamous Carcinoma of the Lung, Japanese Journal of Lung Cancer, 32(4), 543-551, 19920820
  65. Ovarian Sex Cord Tumor with Annular Tubules - A Case Report and Review of the Literature in Japanese., Hiroshima J. Med. Sci., 37-42, 19920201
  66. Quantitative risk assessment of carcinogenicity of urethane (ethyl carbamate) on the basis of long-term oral administration to B6C3F1 mice, 380-385, 19910401
  67. Usefulness of serum S100A4 and positron-emission tomography on lung cancer accompanied by interstitial pneumonia, THORACIC CANCER, 14(4), 381-388, 202302
  68. Challenges and limitation of MTAP immunohistochemistry in diagnosing desmoplastic mesothelioma/sarcomatoid pleural mesothelioma with desmoplastic features, ANNALS OF DIAGNOSTIC PATHOLOGY, 60, 202210
  69. Characteristics and therapeutic strategies of radiation-induced glioma: case series and comprehensive literature review, JOURNAL OF NEURO-ONCOLOGY, 159(3), 531-538, 202209
  70. Downregulation of FTL decreases proliferation of malignant mesothelioma cells by inducing G(1) cell cycle arrest, ONCOLOGY LETTERS, 23(6), 202206
  71. Sensitivity and optimal clinicopathological features for mutation-targeted liquid biopsy in pN0M0 EGFR-mutant lung adenocarcinoma, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 148(6), 1419-1428, 202206
  72. Identification of Novel Diagnostic Markers for Malignant Pleural Mesothelioma Using a Reverse Translational Approach Based on a Rare Synchronous Tumor, DIAGNOSTICS, 12(2), 202202
  73. Intratumoral Hemorrhage After Endoscopic Third Ventriculostomy for Obstructive Hydrocephalus Caused by Brain Tumors, WORLD NEUROSURGERY, 158, E256-E264, 202202
  74. Downregulation of lncRNA PVT1 inhibits proliferation and migration of mesothelioma cells by targeting FOXM1, ONCOLOGY REPORTS, 47(2), 202202
  75. Diffusion-weighted imaging-gadolinium enhancement mismatch sign in diffuse midline glioma, EUROPEAN JOURNAL OF RADIOLOGY, 147, 202202
  76. Clinical Behavior of Combined Versus Pure High-Grade Neuroendocrine Carcinoma, CLINICAL LUNG CANCER, 23(1), E9-+, 202201
  77. Comprehensive analysis of the clinicopathological features, targetable profile, and prognosis of mucinous adenocarcinoma of the lung, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 147(12), 3709-3718, 202112
  78. Pathological high malignant grade is higher risk of recurrence in pN0M0 invasive lung adenocarcinoma, even with small invasive size, THORACIC CANCER, 12(23), 3141-3149, 202112
  79. Tumor contact length of prostate cancer determined by a three-dimensional method on multiparametric magnetic resonance imaging predicts extraprostatic extension and biochemical recurrence, INTERNATIONAL JOURNAL OF UROLOGY, 28(10), 1012-1018, 202110
  80. TUBB3 is associated with PTEN, neuroendocrine differentiation, and castration resistance in prostate cancer, UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 39(6), 202106
  81. Detecting non-germinomatous germ cell tumor component by arterial spin labeling perfusion-weighted MR imaging in central nervous system germ cell tumor, EUROPEAN JOURNAL OF RADIOLOGY, 136, 202103
  82. Bronchial mucosal ablation for bronchial stump closure in right pneumonectomy: a case report., J Med Case Rep, 15(1), 71-71, 202102
  83. Glypican-1 is a novel immunohistochemical marker to differentiate poorly differentiated squamous cell carcinoma from solid predominant adenocarcinoma of the lung., Transl Lung Cancer Res, 10(2), 766-775, 202102
  84. Clinicopathological significance of intelectin-1 in colorectal cancer: Intelectin-1 participates in tumor suppression and favorable progress, PATHOLOGY INTERNATIONAL, 70(12), 943-952, 202012
  85. Radiological and Immunostaining Characteristics of H3.3 G34R-Mutant Glioma: A Report of 3 Cases and Review of the Literature, PEDIATRIC NEUROSURGERY, 55(5), 319-325, 202012
  86. Clinicopathological significance of intelectin-1 in colorectal cancer: Intelectin-1 participates in tumor suppression and favorable progress., Pathol Int, 70(12), 943-952, 202012
  87. Microtubule-associated protein tau (MAPT) promotes bicalutamide resistance and is associated with survival in prostate cancer, UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 38(10), 202010
  88. Microtubule-Associated Protein Tau (Mapt) Promotes Bicalutamide Resistance and Is Associated with Survival in Prostate Cancer., Urol Oncol, 38(10), 319-325, 202010
  89. SOX6 is a Novel Immunohistochemical Marker for Differential Diagnosis of Epithelioid Mesothelioma From Lung Adenocarcinoma, AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 44(9), 1259-1265, 202009
  90. ★, SOX6 Is a Novel Immunohistochemical Marker for Differential Diagnosis of Epithelioid Mesothelioma From Lung Adenocarcinoma., Am J Surg Pathol, 44(9), 1259-1265, 202009
  91. Radiology Profile as a Potential Instrument to Differentiate Between Posterior Fossa Ependymoma (PF-EPN) Group A and B, WORLD NEUROSURGERY, 140, E320-E327, 202008
  92. Radiology Profile as a Potential Instrument to Differentiate between Posterior Fossa Ependymoma (Pf-Epn) Group a and B., World Neurosurg, 140(8), e320-e327, 202008
  93. A Case of Peritoneal Dissemination and Splenic Metastasis after Gastric Cancer Surgery That Could Be Controlled with Multidisciplinary Treatment., Case Rep Oncol, 13(3), 1164-1170, 202008
  94. Advantage of high b value diffusion -weighted imaging for differentiation of common pediatric brain tumors in posterior fossa, EUROPEAN JOURNAL OF RADIOLOGY, 128, 202007
  95. LPrognostic Impact of Programmed Death-ligand 1 and Surrounding Immune Status on Stage I Lung Cancer, CLINICAL LUNG CANCER, 21(4), E302-E314, 202007
  96. Prognostic Impact of Programmed Death-Ligand 1 and Surrounding Immune Status on Stage I Lung Cancer., Clin Lung Cancer, 21(4), e302-e314, 202007
  97. Investigation of surgical technique for bronchial stump closure after lobectomy in animal model, GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 68(6), 609-614, 202006
  98. Inhibition of miR-18a-3p reduces proliferation of mesothelioma cells and sensitizes them to cisplatin, ONCOLOGY LETTERS, 19(6), 4161-4168, 202006
  99. Inhibition of Mir-18a-3p Reduces Proliferation of Mesothelioma Cells and Sensitizes Them to Cisplatin., Oncol Lett, 19(6), 4161-4168, 202006
  100. T2-FLAIR mismatch sign in dysembryoplasticneuroepithelial tumor, EUROPEAN JOURNAL OF RADIOLOGY, 126, 202005
  101. Radiological and Immunostaining Characteristics of H3.3 G34R-Mutant Glioma: A Report of 3 Cases and Review of the Literature., Pediatr Neurosurg, 55(5), 319-325, 202005
  102. Intense Expression of EGFR L858R Characterizes the Micropapillary Component and L858R Is Associated with the Risk of Recurrence in pN0M0 Lung Adenocarcinoma with the Micropapillary Component, ANNALS OF SURGICAL ONCOLOGY, 27(3), 945-955, 202003
  103. Intense Expression of Egfr L858r Characterizes the Micropapillary Component and L858r Is Associated with the Risk of Recurrence in Pn0m0 Lung Adenocarcinoma with the Micropapillary Component., Ann Surg Oncol, 27(3), 945-955, 202003
  104. Magnetic resonance imaging/transrectal ultrasonography fusion targeted prostate biopsy finds more significant prostate cancer in biopsy-naive Japanese men compared with the standard biopsy, INTERNATIONAL JOURNAL OF UROLOGY, 27(2), 140-146, 202002
  105. Utility of dual-energy CT for predicting the vascularity of meningiomas, EUROPEAN JOURNAL OF RADIOLOGY, 123, 202002
  106. Primary and Recurrent Growing Teratoma Syndrome in Central Nervous System Nongerminomatous Germ Cell Tumors: Case Series and Review of the Literature, WORLD NEUROSURGERY, 134, E360-E371, 202002
  107. Magnetic Resonance Imaging/Transrectal Ultrasonography Fusion Targeted Prostate Biopsy Finds More Significant Prostate Cancer in Biopsy-Naive Japanese Men Compared with the Standard Biopsy., Int J Urol., 27(2), 140-146, 202002
  108. A Rare Case of Gastric Schwannoma: A Case Report and Literature Review, Case Rep Oncol., 13(1), 330-335, 202001
  109. Retrospective immunohistological study of autopsied lungs in patients with acute exacerbation of interstitial pneumonia managed with extracorporeal membrane oxygenation, JOURNAL OF THORACIC DISEASE, 11(11), 4436-4443, 201911
  110. Effect of bevacizumab against cystic components of brain tumors, CANCER MEDICINE, 8(15), 6519-6527, 201911
  111. Synchronicity of genetic variants between primary sites and metastatic lymph nodes, and prognostic impact in nodal metastatic lung adenocarcinoma, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 145(9), 2325-2333, 201909
  112. Characteristics of 5015 Salivary Gland Neoplasms Registered in the Hiroshima Tumor Tissue Registry over a Period of 39 Years, JOURNAL OF CLINICAL MEDICINE, 8(5), 201905
  113. Mucin 21 is a novel, negative immunohistochemical marker for epithelioid mesothelioma for its differentiation from lung adenocarcinoma, HISTOPATHOLOGY, 74(4), 545-554, 201903
  114. Increased risk of recurrence in resected EGFR-positive pN0M0 invasive lung adenocarcinoma, THORACIC CANCER, 9(12), 1594-1602, 201812
  115. Perfusion Computed Tomography Parameters Are Useful for Differentiating Glioblastoma, Lymphoma, and Metastasis, WORLD NEUROSURGERY, 119, E890-E897, 201811
  116. Improved differentiation between high- and low-grade gliomas by combining dual-energy CT analysis and perfusion CT, MEDICINE, 97(32), 201808
  117. Glypican-1 immunohistochemistry is a novel marker to differentiate epithelioid mesothelioma from lung adenocarcinoma, MODERN PATHOLOGY, 31(5), 809-815, 201805
  118. Proton Magnetic Resonance Spectroscopy Detection of High Lipid Levels and Low Apparent Diffusion Coefficient Is Characteristic of Germinomas, WORLD NEUROSURGERY, 112, E84-E94, 201804
  119. RELA fusion-positive anaplastic ependymoma: molecular characterization and advanced MR imaging., Brain Tumor Pathol., 35(1), 41-45, 201801
  120. PIM1 knockdown inhibits cell proliferation and invasion of mesothelioma cells, INTERNATIONAL JOURNAL OF ONCOLOGY, 50(3), 1029-1034, 201703
  121. Utility and pitfalls of immunohistochemistry in the differential diagnosis between epithelioid mesothelioma and poorly differentiated lung squamous cell carcinoma, HISTOPATHOLOGY, 70(3), 375-384, 201702
  122. Prognostic significance of vascular invasion in intermediate-grade subtype of lung adenocarcinoma, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 46(11), 1015-1021, 201611
  123. Prognostic Role of Subtype Classification in Small-Sized Pathologic N0 Invasive Lung Adenocarcinoma, ANNALS OF THORACIC SURGERY, 102(5), 1668-1673, 201611
  124. Pleural irregularities and mediastinal pleural involvement in early stages of malignant pleural mesothelioma and benign asbestos pleural effusion, EUROPEAN JOURNAL OF RADIOLOGY, 85(9), 1594-1600, 201609
  125. Fatal pleural mesothelioma in Japan (2003-2008): evaluation of computed tomography findings, JAPANESE JOURNAL OF RADIOLOGY, 34(6), 432-438, 201606
  126. Computed Tomographic Features of Malignant Peritoneal Mesothelioma, ANTICANCER RESEARCH, 36(3), 1067-1072, 201603
  127. Magnetic resonance spectroscopy detection of high lipid levels in intraaxial tumors without central necrosis: a characteristic of malignant lymphoma, JOURNAL OF NEUROSURGERY, 122(6), 1370-1379, 201506
  128. Prognostic impact of lymphatic invasion for pathological stage I squamous cell carcinoma of the lung, GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 63(3), 153-158, 201503
  129. Propensity score-matched analysis of adjuvant chemotherapy for stage I non-small cell lung cancer, JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 148(4), 1179-1185, 201410
  130. Prediction for prognosis of resected pT1a-lbN0M0 adenocarcinoma based on tumor size and histological status: Relationship of TNM and IASLC/ATS/ERS classifications, LUNG CANCER, 85(2), 270-275, 201408
  131. Role of lymphatic invasion in the prognosis of patients with clinical node-negative and pathologic node-positive lung adenocarcinoma., J Thorac Cardiovasc Surg, 147(6), 1820-1826, 201406
  132. The prognostic role of pathologic invasive component size, excluding lepidic growth, in stage I lung adenocarcinoma, JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 146(3), 580-585, 201309
  133. Treatment and survival analyses of malignant mesothelioma in Japan, ACTA ONCOLOGICA, 52(4), 803-808, 201305
  134. CD9 expression as a favorable prognostic marker for patients with malignant mesothelioma, ONCOLOGY REPORTS, 29(1), 21-28, 201301
  135. Role of perfusion-weighted imaging at 3 T in the histopathological differentiation between astrocytic and oligodendroglial tumors, EUROPEAN JOURNAL OF RADIOLOGY, 81(8), 1863-1869, 201208
  136. National survey of malignant mesothelioma and asbestos exposure in Japan, CANCER SCIENCE, 103(3), 483-490, 201203
  137. Lymphomas and glioblastomas: Differences in the apparent diffusion coefficient evaluated with high b-value diffusion-weighted magnetic resonance imaging at 3 T, EUROPEAN JOURNAL OF RADIOLOGY, 81(2), 339-344, 201202
  138. Role of PROPELLER diffusion-weighted imaging and apparent diffusion coefficient in the evaluation of pituitary adenomas, EUROPEAN JOURNAL OF RADIOLOGY, 80(2), 412-417, 201111
  139. Clinical Study on Mesothelioma in Japan: Relevance to Occupational Asbestos Exposure, AMERICAN JOURNAL OF INDUSTRIAL MEDICINE, 53(11), 1081-1087, 201011
  140. Aberrant promoter methylation of WIF-1 and SFRP1, 2, 4 genes in mesothelioma, ONCOLOGY REPORTS, 24(2), 423-431, 201008
  141. TRIGEMINAL NEUROPATHY FROM PERINEURAL SPREAD OF AN AMYLOIDOMA DETECTED BY BLINK REFLEX AND THIN-SLICE MAGNETIC RESONANCE IMAGING, MUSCLE & NERVE, 41(6), 875-878, 201006
  142. Role of PROPELLER diffusion weighted imaging and apparent diffusion coefficient in the diagnosis of sellar and parasellar lesions, EUROPEAN JOURNAL OF RADIOLOGY, 74(3), 420-427, 201006
  143. Evaluation of Apoptosis and Immunohistochemical Expression of the Apoptosis-related Proteins in Mesothelioma, Hiroshima Journal of Medical Sciences, 59(2), 27-33, 201006
  144. Glioblastoma treated with postoperative radio-chemotherapy: Prognostic value of apparent diffusion coefficient at MR imaging, EUROPEAN JOURNAL OF RADIOLOGY, 73(3), 532-537, 201003
  145. Accuracy of pathological diagnosis of mesothelioma cases in Japan: Clinicopathological analysis of 382 cases, LUNG CANCER, 66(2), 191-197, 200911
  146. Caveolin-1 is a novel immunohistochemical marker to differentiate epithelioid mesothelioma from lung adenocarcinoma, HISTOPATHOLOGY, 55(1), 10-19, 200907
  147. ★, Value of immunohistochemistry in the differential diagnosis of pleural sarcomatoid mesothelioma from lung sarcomatoid carcinoma, HISTOPATHOLOGY, 54(6), 667-676, 200905
  148. Clinicopathological and immunohistochemical features of three pilomyxoid astrocytomas: Comparative study with 11 pilocytic astrocytomas, PATHOLOGY INTERNATIONAL, 59(2), 80-85, 200902
  149. Asbestos and lung cancer, 57(9), 2274-2277, 200809
  150. Differential diagnosis of sarcomatoid mesothelioma from true sarcoma and sarcomatoid carcinoma using immunohistochemistry, PATHOLOGY INTERNATIONAL, 58(2), 75-83, 200802
  151. Immunohistochemical marker panels for distinguishing between epithelioid mesothelioma and lung adenocarcinoma, PATHOLOGY INTERNATIONAL, 57(4), 190-199, 200704
  152. Characterization of SEZ6L2 cell-surface protein as a novel prognostic marker for lung cancer, CANCER SCIENCE, 97(8), 737-745, 200608
  153. Expression of vascular endothelial growth factor-C and its receptor in invasive micropapillary carcinoma of the breast, PATHOLOGY INTERNATIONAL, 56(5), 256-261, 200605
  154. Gene amplification and protein expression of EGFR and HER2 by chromogenic in situ hybridisation and immunohistochemistry in atypical adenomatous hyperplasia and adenocarcinoma of the lung, JOURNAL OF CLINICAL PATHOLOGY, 58(10), 1076-1080, 200510
  155. Expression and localization of Reg IV in human neoplastic and non-neoplastic tissues: Reg IV expression is associated with intestinal and neuroendocrine differentiation in gastric adenocarcinoma, JOURNAL OF PATHOLOGY, 207(2), 185-198, 200510
  156. Aberrant methylation and loss of expression of O-6-methylguanine-DNA methyltransferase in pulmonary squamous cell carcinoma and adenocarcinoma, PATHOLOGY INTERNATIONAL, 55(6), 303-309, 200506
  157. Loss of expression of E-cadherin and beta-catenin is associated with progression of pulmonary adenocarcinoma, PATHOLOGY INTERNATIONAL, 55(1), 14-18, 200501
  158. Esophageal carcinosarcoma with basaloid squamous carcinoma and rhabdomyosarcoma components with TP53 mutation, PATHOLOGY INTERNATIONAL, 54(10), 803-809, 200410
  159. Aberrant methylation of p14(ARF), p15(INK4b) and p16(INK4a) genes and location of the primary site in pulmonary squamous cell carcinoma, PATHOLOGY INTERNATIONAL, 54(8), 549-555, 200408
  160. Inactivation of the p16 gene by hypermethylation and loss of heterozygosity in adenocarcinoma of the lung, PATHOLOGY INTERNATIONAL, 54(7), 486-489, 200407
  161. Meningioma in mature cystic teratoma of the ovary, PATHOLOGY INTERNATIONAL, 54(7), 543-548, 200407
  162. Methylation of p14(ARF) gene in meningiomas and its correlation to the p53 expression and mutation, MODERN PATHOLOGY, 17(6), 705-710, 200406
  163. Expression of MUC1, MUC2, MUC5AC, and MUC6 in atypical adenomatous hyperplasia, bronchioloalveolar carcinoma, adenocarcinoma with mixed subtypes, and mucinous bronchioloalveolar carcinoma of the lung, AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 121(5), 644-653, 200405
  164. Myxopapillary ependymoma with anaplastic features, PATHOLOGY INTERNATIONAL, 53(10), 700-703, 200310
  165. Heterogeneity of expression of cytokeratin subtypes in squamous cell carcinoma of the lung: With special reference to CK14 overexpression in cancer of high-proliferative and lymphogenous metastatic potential, PATHOLOGY INTERNATIONAL, 52(4), 286-293, 200204
  166. Meningioangiomatosis occurring in a young male without neurofibromatosis - With special reference to its histogenesis and loss of heterozygosity in the NF2 gene region, AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 26(1), 125-129, 200201
  167. In vivo histological changes occurring in hydroxyapatite cranial reconstruction - Case report, NEUROLOGIA MEDICO-CHIRURGICA, 41(2), 100-104, 200102
  168. 'Adenomyomatous' hamartoma of the lung, PATHOLOGY INTERNATIONAL, 50(12), 984-986, 200012
  169. Correlation between morphological heterogeneity and genetic alteration within one tumor in adenocarcinomas of the lung, PATHOLOGY INTERNATIONAL, 50(11), 891-896, 200011
  170. Correlation between genetic alterations and histopathological subtypes in bronchiolo-alveolar carcinoma and atypical adenomatous hyperplasia of the lung, PATHOLOGY INTERNATIONAL, 50(10), 778-785, 200010
  171. Tubular seminoma of the testis, Pathology International, 49(7), 676-679, 199907
  172. Angiomyofibroblastoma of the vulva : A mitotically active variant?, Pathology International, 48(4), 292-296, 199804
  173. Histopathological and Immunohistochemical Analysis of 6 Cases of Solitary Fibrous Tumor of the Pleura, Japanese Journal of Lung Cancer, 38(2), 117-122, 199804
  174. Solitary fibrous tumor of the prostate, Pathology International, 47(10), 713-717, 199710
  175. Primary carcinoid tumor of the kidney with special reference to its histogenesis, Pathology International, 46(11), 894-900, 199611
  176. Alteration of the p53 gene of lung carcinomas with sarcomatous transformation (spindle cell carcinoma) : Analysis of four cases, Pathol Int., 46(1), 38-45, 199601
  177. ★, p53 mutations in lung cancers from Japanese mustard gas workers., Carcinogenesis, 15(10):2075-9.(10), 2075-2079, 199412
  178. ★, p53 mutations in lung cancers from non-smoking atomic-bomb survivors., 342, 1520-1521, 199312
  179. ★, Insulin-Like Growth Factor 2 mRNA Binding Protein 3 Promotes Cell Proliferation of Malignant Mesothelioma Cells by Downregulating p27/KIP1, Front Oncol, 2022
  180. Diffusion-weighted imaging-gadolinium enhancement mismatch sign in diffuse midline glioma., Eur J Radiol, 147, 110103, 2022
  181. Histopathological Analysis of False-positive Lesions in mpMRI/TRUS Fusion Prostate Biopsy, IN VIVO, 36(1), 496-500, 2022
  182. Metachronous Double Pituitary Adenoma with Altered Transcriptional Factor Profile: A Case Report and Literature Review., NMC Case Rep J, 4(6), 397-402, 2021
  183. The secondary tumor of the prostate derived from upper tract urothelial carcinoma: An autopsy case., IJU Case Rep, 4(6), 397-402, 2021
  184. Utility of Newly Proposed Grading System From International Association for the Study of Lung Cancer for Invasive Lung Adenocarcinoma., JTO Clin Res Rep, 2(2), 100126, 2021
  185. Sensitivity and optimal clinicopathological features for mutation-targeted liquid biopsy in pN0M0 EGFR-mutant lung adenocarcinoma., J Cancer Res Clin Oncol, 2021
  186. Intratumoral Hemorrhage After Endoscopic Third Ventriculostomy for Obstructive Hydrocephalus Caused by Brain Tumors., World Neurosurg, 2021
  187. Primary Small Intestinal Sarcomatoid Carcinoma: Report of a Rare Case and Literature Review, CASE REPORTS IN ONCOLOGY, 14(1), 538-544, 2021
  188. A Rare Case of Gastric Schwannoma: A Case Report and Literature Review, CASE REPORTS IN ONCOLOGY, 13(1), 330-335, 2020
  189. Drug-Induced Interstitial Pneumonia due to Application of FOLFOX as Adjuvant Chemotherapy after Rectal Cancer Surgery: A Case Report and Literature Review, CASE REPORTS IN ONCOLOGY, 13(2), 768-773, 2020
  190. A Case of Peritoneal Dissemination and Splenic Metastasis after Gastric Cancer Surgery That Could Be Controlled with Multidisciplinary Treatment, CASE REPORTS IN ONCOLOGY, 13(3), 1164-1170, 2020
  191. Primary and Recurrent Growing Teratoma Syndrome in Central Nervous System Nongerminomatous Germ Cell Tumors: Case Series and Review of the Literature., World Neurosurg., 134, e360-e371, 2020
  192. Utility of Dual-Energy Ct for Predicting the Vascularity of Meningiomas., Eur J Radiol., 123, 2020
  193. T2-Flair Mismatch Sign in Dysembryoplasticneuroepithelial Tumor., Eur J Radiol, 126, 2020
  194. Advantage of High B Value Diffusion-Weighted Imaging for Differentiation of Common Pediatric Brain Tumors in Posterior Fossa., Eur J Radiol, 2020
  195. Segmentectomy vs. lobectomy for clinical stage IA lung adenocarcinoma with spread through air spaces., Ann Thorac Surg, 2020
  196. Metastatic Malignant Lymphoma Mimicking Cerebral Toxoplasmosis with the "Target Sign", INTERNAL MEDICINE, 58(8), 1157-1162, 2019
  197. Complete Response to Chemotherapy against the Recurrence of Neuroendocrine Carcinoma of the Breast in the Anterior Mediastinal Lymph Nodes of a Patient on Hemodialysis: A Case Report, CASE REPORTS IN ONCOLOGY, 12(1), 205-210, 2019
  198. Immunostaining of Increased Expression of Enhancer of Zeste Homolog 2 (EZH2) in Diffuse Midline Glioma H3K27M-Mutant Patients with Poor Survival, PATHOBIOLOGY, 86(2), 152-161, 2019
  199. Rare Cases of Low-Grade Appendiceal Mucinous Neoplasm: Two Case Reports and a Literature Review, CASE REPORTS IN ONCOLOGY, 12(2), 488-493, 2019
  200. Effect of bevacizumab against cystic components of brain tumors, Cancer Medicine, 8(15), 6519-6527, 2019
  201. Role for loss of nuclear PTEN in a harbinger of brain metastases., 2018
  202. The differences in histological changes among pulmonary vessels divided with an energy device., Interact Cardiovasc Thorac Surg., 2018
  203. Coexistence of gastrointestinal stromal tumor and leiomyosarcoma of the stomach presenting as a collision tumor: A case report and review of literature, Pathology International, 68, 313-317, 2018
  204. Improved differentiation between high- and low-grade gliomas by combining dual-energy CT analysis and perfusion CT., Medicine (Baltimore), 97(32), E11670, 2018
  205. Characteristics of Benign and Malignant Bone Tumors Registered in the Hiroshima Tumor Tissue Registry, 1973-2012., JB JS Open Access., 29(3), e0064, 2018
  206. Increased risk of recurrence in resected EGFR-positive pN0M0 invasive lung adenocarcinoma., Thorac Cancer., 2018
  207. ★, MUC21 is a novel, negative immunohistochemical marker for epithelioid mesothelioma for its differentiation from lung adenocarcinoma., Histopathology, 2018
  208. ★, miR-182 and miR-183 Promote Cell Proliferation and Invasion by Targeting FOXO1 in Mesothelioma, Front. Oncol., 2018
  209. Prognostic Role of Subtype Classification in Small-Sized Pathologic N0 Invasive Lung Adenocarcinoma., Ann Thorac Surg., 102(5), 1668-1673., 2017
  210. ★, MUC4, a novel immunohistochemical marker identified by gene expression profiling, differentiates pleural sarcomatoid mesothelioma from lung sarcomatoid carcinoma., Mod Pathol, 30([Epub ahead of print]), [Epub ahead of print]-[Epub ahead of print], 2017
  211. Multicentric Glioma Develops via a Mutant IDH1-Independent Pathway: Immunohistochemical Study of Multicentric Glioma, PATHOBIOLOGY, 84(2), 99-107, 2017
  212. ★, Identification of DAB2 and Intelectin-1 as Novel Positive Immunohistochemical Markers of Epithelioid Mesothelioma by Transcriptome Microarray Analysis for its Differentiation From Pulmonary Adenocarcinoma., Am J Surg Pathol., 2017
  213. Prognostic implications of the subcellular localization of survivin in glioblastomas treated with radiotherapy plus concomitant and adjuvant temozolomide., J Neurosurg., 2017(21), 2017
  214. Sellar Atypical Teratoid/Rhabdoid Tumor (AT/RT): A Clinicopathologically and Genetically Distinct Variant of AT/RT, Am J Surg Pathol, 41(7), 932-940, 2017
  215. Role for loss of nuclear PTEN in a harbinger of brain metastases, Journal of Clinical Neuroscience, 2017
  216. A comparison of clinicopathological features and prognosis in prostate cancer between atomic bomb survivors and control patients., Oncol Lett., 14(1), 299-305, 2017
  217. Inflammatory myofibroblastic tumors of the lung carrying a chimeric A2M-ALK gene: report of two infantile cases and review of the differential diagnosis of infantile pulmonary lesions., Hum Pathol., 2017, 2017
  218. Nonenhancing peritumoral hyperintense lesion on diffusion-weighted imaging in glioblastoma: a novel diagnostic and specific prognostic indicator., J Neurosurg, 2017
  219. ★, Use of Anti-Noxa Antibody for Differential Diagnosis between Epithelioid Mesothelioma and Reactive Mesothelial Hyperplasia., Pathobiology, 83((1):), 33-40, 2016
  220. ★, Differential microRNA expression profiling of mesothelioma and expression analysis of miR-1 and miR-214 in mesothelioma, International Journal of Oncology, 48(4), 1599-1607, 2016
  221. Benign fibrous histiocytoma arising at the temporal bone of an infant-case report and review of the literature., Childs Nerv Syst, [Epub ahead of print]([Epub ahead of print]), 2015
  222. CD26 overexpression is associated with prolonged survival and enhanced chemosensitivity in malignant pleural mesothelioma., Clin Cancer Res, 18(5), 1447-1456, 2012
  223. Clinical, Radiological, and Pathological Investigation of Asbestosis, INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 8(3), 899-912, 2011
  224. Overexpression of CD26/DPPIV in mesothelioma tissue and mesothelioma cell lines, ONCOLOGY REPORTS, 26(6), 1369-1375, 2011
  225. Clinical Study on Mesothelioma in Japan: Relevance to Occupational Asbestos Exposure, AMERICAN JOURNAL OF INDUSTRIAL MEDICINE, 53(11), 1081-1087, 2010
  226. WIF1 expression is down-regulated by its promoter methylation in mesothelioma, JOURNAL OF THORACIC ONCOLOGY, 4(9), S767-S767, 2009
  227. Familial occurrence of dysembryoplastic neuroepithelial tumor-like neoplasm of the septum pellucidum: Case report, NEUROSURGERY, 63(2), 370-372, 2008
  228. A Useful Antibody Panel for Differential Diagnosis Between Peritoneal Mesothelioma and Ovarian Serous Carcinoma in Japanese Cases, AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 130(5), 771-779, 2008
  229. Immunohistochemical marker panels for distinguishing between epithelioid mesothelioma and lung adenocarcinoma, PATHOLOGY INTERNATIONAL, 57(4), 190-199, 2007
  230. A case of micronodular pneumocyte hyperplasia diagnosed through lung biopsy using thoracoscopy, RESPIRATION, 69(3), 277-279, 2002
  231. Extra-abdominal desmoid tumor presenting as an intrathoracic tumor: Case report and literature review, PATHOLOGY INTERNATIONAL, 51(10), 824-828, 2001
  232. Genetic alterations in ovarian mucinous tumors - With special reference to the histogenesis, ACTA HISTOCHEMICA ET CYTOCHEMICA, 33(2), 123-129, 2000
  233. A case of malignant pericardial mesothelioma with secondary pulmonary hypertension due to pulmonary vein occulusion:Comprehensive review of 56 cases reported in Japan, Shinzo, 32(5), 438-445, 2000
  234. Immunohistochemical and Molecular Pathological Analysis of Cell Cycle-related Factors in Human Multistep Carcinogenesis, Acta histochemica et cytochemica, 32(6), 1999
  235. Abstracts:THE 40TH MEMORIAL SCIENTIFIC MEETING OF THE JAPAN SOCIETY OF HISTOCHEMISTRY AND CYTOCHEMISTRY, Proceedings of the Japanese Histochemical Association, 32(6), 502-516, 1999
  236. Histopathological former workers engaged in mustard gas factory, Med J Hiroshima Univ, 38, 853-863, 1990
  237. Idipatic granulomatous meningoencepalitis presenting as an intracranial tumor, Pathology International, 49, 1084-1088
  238. Immunohistochemical study of Ki-67 (MIB-1), p53 protein, p21WAF1, p27KIP1expression in benign, atypical, and anplastic meningiomas, Human Pathology, 32, 970-975

Publications such as books

  1. 1991, Sporadic, Late-Onset Case of Familial Amyloid Polyneuropathy Type I (Andrade), A Clinical Study. , Kluwer Academic Publ., 1991, Joint work

Invited Lecture, Oral Presentation, Poster Presentation

  1. Pathological Diagnosis of Mesothelioma Using Immunohistochemistry, Yukio Takeshima, JICA project "The improvement of diagnostic ability in early phase of pneumoconiosis and asbestosis-exposure related respiratory disease", 2019/11/19, Without Invitation, English, other
  2. Pathological diagnosis of lung cancer, Yukio Takeshima, JICA project "The improvement of diagnostic ability in early phase of pneumoconiosis and asbestosis-exposure related respiratory disease", 2019/06/27, Without Invitation, English, other
  3. Practice and Utility of Immunohistochemistry and genetic analysis for Pathological Diagnosis, Yukio Takeshima, JICA project "The improvement of diagnostic ability in early phase of pneumoconiosis and asbestosis-exposure related respiratory disease", 2019/06/27, Without Invitation, English, Ulaanbaatar, Mongolia, other
  4. Diagnostic utility of MUC4 expression to differentiate epithelioid mesothelioma from lung adenocarcinoma and squamous cell carcinoma, Amatya V.J., Mawas A.S., Kushitani K., Kai Y., Miyata Y., Okada M. and Takeshima Y., IASLC 18th World Conference on Lung Cancer, 2017/10/15, Without Invitation, English, published
  5. Identification of DAB2 and Intelection-1 as novel positive immunohistochemical markers of epithelioid mesothelioma, Kushitani K., Amatya V.J., Okada Y., Katayama Y., Mawas A.S., Miyata Y., Okada M., Inai K., Kishimoto T. and Takeshima Y., IASLC 18th World Conference on Lung Cancer, 2017/10/15, Without Invitation, English, experimental
  6. Usefulness of immunohistochemistry in the differential diagnosis of epithelioid mesothelioma and lung squamous cell carcinoma, Kushitani K., Amatya V.J., Okada Y., Katayama Y., Mawas A.S., Miyata Y., Okada M., Inai K., Kishimoto T. and Takeshima Y., IASLC 18th World Conference on Lung Cancer, 2017/10/15, Without Invitation, English, published
  7. Therapeutic strategies and genetic comparisons in SCLC and LCNEC of the lung using next-generation sequencing, Ito M., Miyata Y., Hirano S., Kimura S., Irisuna F., Kushitani K., Tsutani Y., Takeshima Y. and Okada M., IASLC 18th World Conference on Lung Cancer, 2017/10/15, With Invitation, English, published

Social Activities

History as Peer Reviews of Academic Papers

  1. 2014, Pathology International, Editor, Editorial board
  2. 2015, Pathology International, Editor, Editorial board
  3. 2015, Hiroshima J Medical Sciences, Editor
  4. 2016, Pathobiology, Others, Reviewer, 2
  5. 2016, Cancer Science, Others, Reviewer, 1
  6. 2016, Pathology International, Editor
  7. 2016, Pathology International, Others, reviwer, 1
  8. 2016, Hiroshima J Medical Sciences, Editor
  9. 2017, Pathology International, Editor, Editor, 1